Hematologic dysfunction in cancer: mechanisms, effects on antitumor immunity, and roles in disease progression

HIGHLIGHTS

  • who: Viktoria Plackoska from the University of Salford, United Kingdom have published the research: Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression, in the Journal: (JOURNAL)
  • what: In this study tumor specific overexpression of PDGF-BB in the T241 fibrosarcoma and LLC lung carcinoma cells subcutaneously inoculated into mouse models was shown to induce erythropoietin production by stromal cells, stimulating extramedullary erythropoiesis in both spleen and liver, and promoting angiogenesis and tumor growth . however impair DC infiltration and activation, and induce immunosuppressive DC states .
  • future: The exact . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?